News: Gene Therapy For Rare Forms Of Blindness Will Cost Nearly Half A Million Per Eye |
The pharmaceutical company behind a gene therapy for inherited blindness has announced the product’s price, and sticker shock has sent news outlets worldwide into a collective tizzy. Spark Therapeutics plans to charge $425,000 per eye for the therapy, called Luxturna, making it the most expensive drug ever marketed in the US. The landmark FDA approval of Luxturna in December 2017 represented the first approval of a gene therapy for an inherited condition, and only the third-ever approval of a gene therapy. Read more... |
News: Gene therapy shows 'mind-blowing' success in treating haemophilia A |
A new gene therapy for haemophilia A has exceeded expectations in a recent clinical trial. All seven patients who received the high-dose therapy to correct a faulty gene for a crucial blood clotting protein showed considerable improvement. 'This is huge,' Professor John Pasi, who led the trial at Barts and Queen Mary University of London told the BBC. He added that having 'the option to think about normalising levels' of the blood clotting protein factor VIII in patients with severe haemophilia was 'mind-blowing'. Gene therapy could be a potential 'cure' for haemophilia, suggested an editorial accompanying the study published in the New England Journal of Medicine. Read more... |
Conference: 3rd Annual Genome Editing & Engineering Conference |
Having completed two extremely successful editions, 3rd Annual Genome Editing & Engineering Conference taking place on 8th- 9th February 2017 in San Diego, USA aims at brings together the key industry leaders, experts and researchers to address the most recent case studies and research on functional genome screening and precision gene editing to reveal their potential applications. Read more and register... |
Conference: Cell Therapy Manufacturing Asia Congress |
A Brand new Cell Therapy Manufacturing event will be launched in Asia on 28th February - 1st March 2018, in Kyoto, Japan focusing on key topics in manufacturing across cell & gene therapy. Bringing together key influencers from pharma and biotech companies across the world, our Cell Therapy Manufacturing Asia Congress will provide you with the latest advice for driving manufacturing and commercialisation through direct access to innovative research transforming cell manufacturing. Read more and register... |
Conference: CAR-T Congress USA |
CAR-T was the star of 2017, register by 12.01.2018 & save $400 to hear more about its future Following a successful year of FDA approvals in both USA and Europe, along with Gilead’s recent acquisition of Cell Design Labs, as well as Celgene and bluebirdbio’s latest launch into their next phase of their BMCA-targeting study…2018 should be a pivotal year for CAR-T! Join 25+ industry leaders on 20-22 March 2018 to learn more about the latest innovations in manufacturing, use of alternative CARs constructs, as well as how to tackle solid tumors at the CAR-T Congress USA. Read more and register... |
Conference: International conference on Stem Cells and Regenerative Medicine |
International Conference on Stem Cells and Regenerative Medicine is a global event going to be held in Osaka, Japan on 18-19 June, 2018 with the theme “Stem cells : A customized approach for well being”. This international meet (Stem Cell Congress 2018) anticipates hundreds of delegates including keynote speakers, Oral presentations by renowned speakers and poster presentations by students besides delegates around the world. Stem Cell Congress 2018 is an exclusive platform for scientists and young researchers to share their recent and exciting innovations in prominent areas of tissue engineering technology and stem cells research. It will encompass modern day research and findings in Stem cell therapies and research, tissue engineering and transplantations, scope and future of regenerative medicine, current understanding of nanotechnology in regenerative medicine, reprogramming of stem cells, advancements in Cancer stem cells research and the unending possibilities of genome manipulation in stem cell research. All honorable authors, researchers, scientists and students are encouraged to contribute and help the shape of the conference through submissions of their posters & research abstracts. Read more and register... |
Conferences |
- |
23 - 24 January 2018, Patients as Partners Europe Conference, London, UK |
- |
23 - 25 January 2018, Cell & Gene Therapy World event 2018, Miami, Fl |
- |
30 - 31 January 2018, Combined CAR-T Congress Europe, Berlin, Germany |
- |
7 - 8 February 2018, Annual Cell and Gene Therapy Innovation Summit, Berlin, Germany |
- |
8 - 9 February 2018, 3rd Annual Genome Editing & Engineering Conference, San Diego, CA |
- |
28 February - 1 March 2018, Cell Therapy Manufacturing Asia 2018, Kyoto, Japan |
- |
5 - 7 March 2018, International Society for BioProcess Technology 8th Spring Meeting - Viral vectors and vaccines, Norfolk, Virginia |
- |
14 – 16 March 2018, 9th Biennial Congress of the Spanish Society of Gene (SETGyC) and Cell Therapy, Palma de Mallorca, Spain |
- |
15 March 2018, British Society for Gene and Cell Therapy (BSGCT) Public Engagement 2018, Oxford, UK |
- |
15 - 16 March 2018, Spring Symposium of the Netherlands Society of Gene & Cell Therapy (NVGCT), Lunteren, The Netherlands |
- |
15 - 16 March 2018, 7th International Conference and Exhibition on Cell and Gene Therapy, London, UK |
- |
20 - 22 March 2018, CAR-T Congress USA, Boston, MA |
- |
9 - 12 April 2018, 11th International Oncolytic Virus Conference, Oxford, UK |
- |
25-26 April 2018, Global Experts Meeting on Cell and Gene Therapy, Dubai, UAE |
- |
27 April 2018, Annual conference of the British Society for Gene and Cell Therapy (BSGCT), Cardiff, Wales, UK |
- |
30 April - 2 May 2018, Gene Therapy for Rare Disorders Summit, Boston, MA |
- |
2 - 5 May 2018, International Society for Cellular Therapy (ISCT) Annual Meeting, Montreal, Canada |
- |
10 - 11 May 2018, 2nd Annual Genome Editing USA Congress, Boston, MA |
- |
16 - 19 May 2018, American Society of Gene and Cell Therapy (ASGCT) 21th Annual Meeting, Chicago, IL |
- |
15 - 20 June 2018, Monolith Summer School and Symposium (MSS) - Bioprocessing of macromolecules and viruses, Portorož, Slovenia |
- |
18 - 19 June 2018, International conference on Stem Cells and Regenerative Medicine - Genome editing for targeting genetic diseases, Osaka, Japan |
- |
23 - 24 July 2018, Annual Congress on Advanced Tissue Science and Regenerative Medicine, Rome, Italy |
- |
26 - 28 July 2018, The 24th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan |
- |
13 - 16 August 2018, Gene Therapy Bioproduction Conference, Boston, MA |
- |
16 – 19 October 2018, XXVI Congress of the European Society of Gene and Cell Therapy (ESGCT), Lausanne, Swizterland |
- |
9-10 November 2018, 2nd Annual Summit on Cell Therapy and Stem Cell Research 2018 Conference, Atlanta, GA |
- |
23 November 2018, British Society for Gene and Cell Therapy (BSGCT) Annual Conference Autumn 2018, London, UK |
- |
November 2018, 4th Annual Genome Editing UK Congress, London, UK |
- |
29 April - 2 May 2019, American Society of Gene and Cell Therapy (ASGCT) 22th Annual Meeting, Washington, DC |
- |
28 – 31 October 2019, XXVII Congress of the European Society of Gene and Cell Therapy (ESGCT), Barcelona, Spain |
|
Read more... |
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
|
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}. |
|